Todd Gleeson, Kyle Petersen, John Mascola. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Acinetobacter/pathogenicityAcinetobacter Infections/drug therapyAdultAnti-Bacterial Agents/therapeutic useCerebrospinal Fluid/microbiologyDrug Therapy, CombinationFemaleHumansMeningitis, Bacterial/drug therapyMeropenemMicrobial Sensitivity TestsRifampin/therapeutic useSubarachnoid Hemorrhage/surgeryThienamycins/therapeutic useVentriculostomy
Substances： See more » Anti-Bacterial AgentsThienamycinsMeropenemRifampin
Year: 2005 PMID： 16046467 DOI： 10.1093/jac/dki274
Source DB: PubMed Journal: J Antimicrob Chemother ISSN： 0305-7453 Impact factor: 5.790